FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2374993604> ?p ?o ?g. }

• W2374993604 endingPage "38003" @default.
• W2374993604 startingPage "37993" @default.
• W2374993604 abstract "The TMPRSS2-ERG fusion occurs in approximately 50% of prostate cancer (PCa), resulting in expression of the oncogenic ERG in the prostate. Because ERG is a transcriptional activator, we hypothesized that ERG-regulated genes contribute to PCa development. Since microRNA (miRNA) has crucial functions in cancer, we searched for miRNAs regulated by ERG in PCas. We mined published datasets based on the MSKCC Prostate Oncogene Project, in which a comprehensive analysis defined the miRNA transcriptomes in 113 PCas. We retrieved the miRNA expression datasets, and identified miRNAs differentially expressed between ERG-positive and ERG-negative samples. Out of 369 miRNAs, miR-200a, -200b, -429 and -205 are the only miRNAs significantly increased in ERG-positive tumors. Strikingly, miR-200a, -200b and -429 are transcribed as a single polycistronic transcript, suggesting they are regulated at the transcriptional level. With ChIP-qPCR and in vitro binding assay, we identified two functional ETS motifs in the miR-200b/a/429 gene promoter. Knockdown of ERG in PCa cells reduced expression of these three miRNAs. In agreement with the well-established tumor suppressor function, overexpression of the miR-200b/a/429 gene inhibited PCa cell growth and invasion. In summary, our study reveals that miR-200b/a/429 is an ERG target gene, which implicates an important role in TMPRSS2/ERG-dependent PCa development. Although induction of the tumor suppressive miR-200b subfamily by oncogenic ERG appears to be counterintuitive, it is consistent with the observation that the vast majority of primary prostate cancers are slow-growing and indolent." @default.
• W2374993604 created "2016-06-24" @default.
• W2374993604 creator A5000250184 @default.
• W2374993604 creator A5045261173 @default.
• W2374993604 creator A5065153594 @default.
• W2374993604 creator A5065643681 @default.
• W2374993604 creator A5066263660 @default.
• W2374993604 creator A5071368198 @default.
• W2374993604 creator A5073216396 @default.
• W2374993604 creator A5088888083 @default.
• W2374993604 date "2016-05-13" @default.
• W2374993604 modified "2023-10-16" @default.
• W2374993604 title "The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors" @default.
• W2374993604 cites W1945953671 @default.
• W2374993604 cites W1967007963 @default.
• W2374993604 cites W1976324983 @default.
• W2374993604 cites W1976677295 @default.
• W2374993604 cites W1980145933 @default.
• W2374993604 cites W1983453097 @default.
• W2374993604 cites W1983991097 @default.
• W2374993604 cites W1985055097 @default.
• W2374993604 cites W1985563073 @default.
• W2374993604 cites W1986799557 @default.
• W2374993604 cites W1998076166 @default.
• W2374993604 cites W2005304320 @default.
• W2374993604 cites W2007881573 @default.
• W2374993604 cites W2009229545 @default.
• W2374993604 cites W2010215928 @default.
• W2374993604 cites W2015371712 @default.
• W2374993604 cites W2021839205 @default.
• W2374993604 cites W2038167014 @default.
• W2374993604 cites W2045865134 @default.
• W2374993604 cites W2049205984 @default.
• W2374993604 cites W2050079849 @default.
• W2374993604 cites W2054177477 @default.
• W2374993604 cites W2056895315 @default.
• W2374993604 cites W2059848983 @default.
• W2374993604 cites W2061891797 @default.
• W2374993604 cites W2062290101 @default.
• W2374993604 cites W2069104846 @default.
• W2374993604 cites W2077038168 @default.
• W2374993604 cites W2079077785 @default.
• W2374993604 cites W2079298594 @default.
• W2374993604 cites W2080844574 @default.
• W2374993604 cites W2083158631 @default.
• W2374993604 cites W2085592081 @default.
• W2374993604 cites W2087207490 @default.
• W2374993604 cites W2094818686 @default.
• W2374993604 cites W2102107106 @default.
• W2374993604 cites W2103211592 @default.
• W2374993604 cites W2107633226 @default.
• W2374993604 cites W2108527275 @default.
• W2374993604 cites W2110170410 @default.
• W2374993604 cites W2113645544 @default.
• W2374993604 cites W2119337308 @default.
• W2374993604 cites W2119488490 @default.
• W2374993604 cites W2121158863 @default.
• W2374993604 cites W2125120607 @default.
• W2374993604 cites W2133226725 @default.
• W2374993604 cites W2135314242 @default.
• W2374993604 cites W2138885372 @default.
• W2374993604 cites W2141198558 @default.
• W2374993604 cites W2142924577 @default.
• W2374993604 cites W2143207688 @default.
• W2374993604 cites W2144038313 @default.
• W2374993604 cites W2144154026 @default.
• W2374993604 cites W2144469127 @default.
• W2374993604 cites W2145010689 @default.
• W2374993604 cites W2153853712 @default.
• W2374993604 cites W2155131748 @default.
• W2374993604 cites W1977372263 @default.
• W2374993604 doi "https://doi.org/10.18632/oncotarget.9366" @default.
• W2374993604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5122366" @default.
• W2374993604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27191272" @default.
• W2374993604 hasPublicationYear "2016" @default.
• W2374993604 type Work @default.
• W2374993604 sameAs 2374993604 @default.
• W2374993604 citedByCount "21" @default.
• W2374993604 countsByYear W23749936042017 @default.
• W2374993604 countsByYear W23749936042018 @default.
• W2374993604 countsByYear W23749936042019 @default.
• W2374993604 countsByYear W23749936042020 @default.
• W2374993604 countsByYear W23749936042021 @default.
• W2374993604 countsByYear W23749936042022 @default.
• W2374993604 countsByYear W23749936042023 @default.
• W2374993604 crossrefType "journal-article" @default.
• W2374993604 hasAuthorship W2374993604A5000250184 @default.
• W2374993604 hasAuthorship W2374993604A5045261173 @default.
• W2374993604 hasAuthorship W2374993604A5065153594 @default.
• W2374993604 hasAuthorship W2374993604A5065643681 @default.
• W2374993604 hasAuthorship W2374993604A5066263660 @default.
• W2374993604 hasAuthorship W2374993604A5071368198 @default.
• W2374993604 hasAuthorship W2374993604A5073216396 @default.
• W2374993604 hasAuthorship W2374993604A5088888083 @default.
• W2374993604 hasBestOaLocation W23749936041 @default.
• W2374993604 hasConcept C103796816 @default.
• W2374993604 hasConcept C104317684 @default.
• W2374993604 hasConcept C121608353 @default.

• next